Glanbia Nutritionals is the exclusive distributor for pTeroPure brand pterostilbene in North America.
Pterostilbene is an antioxidant derived from berries. Pharmalogically similar to resveratrol, pterostilbene is linked to potential heart health, cognitive, and anti-aging benefits. The nature-identical pTeroPure was developed and patented by ChromaDex Corp. (Irvine, CA).
"We are looking forward to the national expansion of pTeroPure and its adoption into numerous consumer products," said ChromaDex founder and CEO Frank Jaksch. "Glanbia, together with its superb sales, marketing, and R&D teams, is an ideal partner for ChromaDex. With our recently announced pTeroPure clinical safety results and the forthcoming human efficacy data, Glanbia should be well positioned to bring our exciting, novel, patented, and proven ingredient to the food and beverage, dietary supplement, and animal health markets."
Chromadex reports that its ingredient is currently being assessed in a human clinical trial for potential blood pressure, cholesterol, and oxidative stress support.